Wolfe Research analyst Alexandria Hammond reiterated an Outperform rating and $1,250.00 price target on Eli Lilly (NYSE: LLY).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments

TD Cowen Reiterates Hold Rating on Hims and Hers (HIMS)February 6, 2026 6:04 AM Truist: 'Defending Lilly: LLY strong position helps guard their share in a crowded GLP-1 landscape'February 5, 2026 12:35 PM Leerink: 'there is no reason why HIMS shouldn't evaluate these launches for every subsequent weight loss product'February 5, 2026 10:25 AM